Intuity Medical gets new CEO, George Zamanakos, months after ditching IPO plans


The glucose blood test maker pulled the plug in June on plans for an initial public offering in which it had hoped to raise about $75 million.

Previous KeyBank names new Denver-based head of business banking
Next Walk-On's Sports Bistreaux to add 3 more Orlando restaurants